✦ LIBER ✦

Preclinical PK/PD modeling and human efficacious dose projection for a glucokinase activator in the treatment of diabetes

✍ Scribed by Zager, Michael G.; Kozminski, Kirk; Pascual, Bernadette; Ogilvie, Kathleen M.; Sun, Shaoxian

Book ID: 121536589
Publisher: Springer
Year: 2014
Tongue: English
Weight: 371 KB
Volume: 41
Category: Article
ISSN: 1573-8744
DOI: 10.1007/s10928-014-9351-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The application of mechanism-based PK/PD

The application of mechanism-based PK/PD modeling in pharmacodynamic-based dose selection of muM17, a surrogate monoclonal antibody for efalizumab

✍ Benjamin Wu; Amita Joshi; Song Ren; Chee Ng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

muM17 is an anti-mouse CD11a monoclonal antibody (mAb) developed as a surrogate molecule for assessing potential reproductive toxicities of efalizumab, an anti-human CD11a mAb approved for treatment of chronic moderate to severe plaque psoriasis. This article shows the use of a mechanism-based PK/PD

Preclinical pharmacokinetics of MFGR1877

Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma

✍ Amrita V. Kamath; Dan Lu; Priyanka Gupta; Denise Jin; Yan Xin; Ann Brady; Jean-P 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 426 KB

Characterization of preclinical in vitro

Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA-14, a new dopamine D 3 receptor antagonist candidate for treatment of drug addiction

✍ Liu, Fei; Zhuang, Xiaomei; Yang, Cuiping; Li, Zheng; Xiong, Shan; Zhang, Zhiwei; 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Enhanced local dendritic cell activity a

Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model

✍ Koichiro Saito; Koji Araki; Nishant Reddy; Wei Guang; Bert W. O'Malley Jr; Daqin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract ## Background. Radiofrequency ablation (RFA) is a minimally invasive tumor destruction technique and can provide the antigen source initiating tumor immunity. However, induced immune response is weak and requires additional immunotherapy for optimized RFA treatment against cancer. ##